首页 > 最新文献

Indian Journal of Medical Specialities最新文献

英文 中文
Large cell neuroendocrine carcinoma of the lung in posttuberculosis cavity 肺结核后腔的大细胞神经内分泌癌
IF 0.6 Q4 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-10-01 DOI: 10.4103/injms.injms_23_22
M. Abdulla
A 73-year-old male was admitted with hemoptysis for 2 months. He was diagnosed to have sputum-positive pulmonary tuberculosis 4 years back and was treated with antitubercular drugs for 6 months. Contrast-enhanced computed tomography (CT) of the thorax at that time revealed a cavitary lesion with surrounding consolidation in the right lower lobe of the lung. Contrast-enhanced CT of the chest during present admission showed a mass lesion in the lower lobe of the right lung, which was diagnosed as large cell neuroendocrine carcinoma of the lung on histopathological examination. We describe a patient who developed large cell neuroendocrine carcinoma of the lung in a posttuberculosis cavity which, to our knowledge, is the first such report.
一名73岁男性因咳血入院2个月。4年前,他被诊断为痰阳性肺结核,并接受了6个月的抗结核药物治疗。当时胸部的对比增强计算机断层扫描(CT)显示右肺下叶有空洞性病变,周围有实变。本次入院期间胸部增强CT显示右肺下叶有肿块,组织病理学检查诊断为肺大细胞神经内分泌癌。我们描述了一名在结核后腔中发展为肺大细胞神经内分泌癌的患者,据我们所知,这是第一例此类报告。
{"title":"Large cell neuroendocrine carcinoma of the lung in posttuberculosis cavity","authors":"M. Abdulla","doi":"10.4103/injms.injms_23_22","DOIUrl":"https://doi.org/10.4103/injms.injms_23_22","url":null,"abstract":"A 73-year-old male was admitted with hemoptysis for 2 months. He was diagnosed to have sputum-positive pulmonary tuberculosis 4 years back and was treated with antitubercular drugs for 6 months. Contrast-enhanced computed tomography (CT) of the thorax at that time revealed a cavitary lesion with surrounding consolidation in the right lower lobe of the lung. Contrast-enhanced CT of the chest during present admission showed a mass lesion in the lower lobe of the right lung, which was diagnosed as large cell neuroendocrine carcinoma of the lung on histopathological examination. We describe a patient who developed large cell neuroendocrine carcinoma of the lung in a posttuberculosis cavity which, to our knowledge, is the first such report.","PeriodicalId":43811,"journal":{"name":"Indian Journal of Medical Specialities","volume":"13 1","pages":"249 - 250"},"PeriodicalIF":0.6,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47479038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is the fight against COVID-19 falling prey to vaccine hesitancy? 抗击新冠肺炎的斗争是否成为疫苗犹豫的牺牲品?
IF 0.6 Q4 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-10-01 DOI: 10.4103/injms.injms_131_22
A. Prakash, Ramesh Aggarwal
{"title":"Is the fight against COVID-19 falling prey to vaccine hesitancy?","authors":"A. Prakash, Ramesh Aggarwal","doi":"10.4103/injms.injms_131_22","DOIUrl":"https://doi.org/10.4103/injms.injms_131_22","url":null,"abstract":"","PeriodicalId":43811,"journal":{"name":"Indian Journal of Medical Specialities","volume":"13 1","pages":"209 - 210"},"PeriodicalIF":0.6,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46473261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A paraneoplastic optic neuropathy revealing a pulmonary epidermal carcinoma 副肿瘤性视神经病变显示肺表皮癌
IF 0.6 Q4 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-10-01 DOI: 10.4103/injms.injms_42_22
Y. Mouzari, I. Fiqhi, Belfaiza Soukaina, T. Abdellaoui, M. Allaoui, K. Reda, A. Oubaaz
Paraneoplastic optic neuropathy is a relatively rare ocular manifestation. We report the case of a patient with bilateral papilledema revealing a pulmonary squamous cell carcinoma. Paraneoplastic neuropathy is linked to an immune reaction by the presence of autoantibodies against collapsin responsive mediator protein 5 . Diagnosis is based on the determination of these autoantibodies and the search for occult cancer by PET scan.Treatment is often based on corticosteroid therapy and sometimes immunosuppressive treatment is necessary in the case of corticosteroid unresponsiveness.
副肿瘤性视神经病变是一种相对罕见的眼部表现。我们报告了一例双侧视乳头水肿的患者,显示为肺鳞状细胞癌。副肿瘤性神经病与免疫反应有关,这是由于存在抗组织蛋白酶反应介质蛋白5的自身抗体。诊断是基于这些自身抗体的测定和通过PET扫描寻找隐性癌症。治疗通常基于皮质类固醇治疗,有时在皮质类固醇无反应的情况下需要免疫抑制治疗。
{"title":"A paraneoplastic optic neuropathy revealing a pulmonary epidermal carcinoma","authors":"Y. Mouzari, I. Fiqhi, Belfaiza Soukaina, T. Abdellaoui, M. Allaoui, K. Reda, A. Oubaaz","doi":"10.4103/injms.injms_42_22","DOIUrl":"https://doi.org/10.4103/injms.injms_42_22","url":null,"abstract":"Paraneoplastic optic neuropathy is a relatively rare ocular manifestation. We report the case of a patient with bilateral papilledema revealing a pulmonary squamous cell carcinoma. Paraneoplastic neuropathy is linked to an immune reaction by the presence of autoantibodies against collapsin responsive mediator protein 5 . Diagnosis is based on the determination of these autoantibodies and the search for occult cancer by PET scan.Treatment is often based on corticosteroid therapy and sometimes immunosuppressive treatment is necessary in the case of corticosteroid unresponsiveness.","PeriodicalId":43811,"journal":{"name":"Indian Journal of Medical Specialities","volume":"13 1","pages":"251 - 253"},"PeriodicalIF":0.6,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45001016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of reference management software among Allopathy, Ayurveda, and Homeopathy practices 在对抗疗法、阿育吠陀和顺势疗法实践中使用参考管理软件
IF 0.6 Q4 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-10-01 DOI: 10.4103/injms.injms_95_22
Ellora Barman, B. Barman, A. Nune, A. Nongpiur
Background: Reference management software (RMS) enable researchers to organize and manage large number of references that are typically identified during the publication of research articles. Aims and Objectives: The purpose of our study was to determine the extent to which faculties from allopathy, homeopathy, and Ayurveda use RMS for their academic pursuits and to identify which methods are used most frequently. Methods: The survey was circulated among the faculties of three different disciplines of the health-care system to collect respondent demographic details and questionnaire responses. Data distribution and variable type were used to perform descriptive analysis. Results: The data from 114/150 respondents were analyzed. Of the 114 faculties who responded to our survey, 72 (63%) reported using RMS to publish their articles. Knowledge of how to use RMS software is common in allopathic faculties (40%), followed by homeopathy (14%) and Ayurveda (9%). Zotero (41%) is the most popular RMS software among users, followed by Mendeley (31%) and Endnote (12%). Conclusion: Despite being underreported, RMS software is frequently used for the needs of authors from various disciplines in the health-care system.
背景:参考文献管理软件(RMS)使研究人员能够组织和管理在研究论文发表期间通常识别的大量参考文献。目的和目的:我们研究的目的是确定对抗疗法、顺势疗法和阿育吠陀的院系在学术追求中使用RMS的程度,并确定哪种方法使用最频繁。方法:在卫生保健系统三个不同学科的院系中进行调查,收集调查对象的人口统计资料和问卷回答。采用数据分布和变量类型进行描述性分析。结果:对114/150名受访者的数据进行了分析。在114个回应我们调查的院系中,72个(63%)表示使用RMS发表他们的文章。了解如何使用RMS软件在对抗疗法院系中很常见(40%),其次是顺势疗法(14%)和阿育吠陀(9%)。Zotero(41%)是用户中最受欢迎的RMS软件,其次是Mendeley(31%)和Endnote(12%)。结论:尽管被低估,RMS软件经常用于满足卫生保健系统中不同学科作者的需求。
{"title":"Use of reference management software among Allopathy, Ayurveda, and Homeopathy practices","authors":"Ellora Barman, B. Barman, A. Nune, A. Nongpiur","doi":"10.4103/injms.injms_95_22","DOIUrl":"https://doi.org/10.4103/injms.injms_95_22","url":null,"abstract":"Background: Reference management software (RMS) enable researchers to organize and manage large number of references that are typically identified during the publication of research articles. Aims and Objectives: The purpose of our study was to determine the extent to which faculties from allopathy, homeopathy, and Ayurveda use RMS for their academic pursuits and to identify which methods are used most frequently. Methods: The survey was circulated among the faculties of three different disciplines of the health-care system to collect respondent demographic details and questionnaire responses. Data distribution and variable type were used to perform descriptive analysis. Results: The data from 114/150 respondents were analyzed. Of the 114 faculties who responded to our survey, 72 (63%) reported using RMS to publish their articles. Knowledge of how to use RMS software is common in allopathic faculties (40%), followed by homeopathy (14%) and Ayurveda (9%). Zotero (41%) is the most popular RMS software among users, followed by Mendeley (31%) and Endnote (12%). Conclusion: Despite being underreported, RMS software is frequently used for the needs of authors from various disciplines in the health-care system.","PeriodicalId":43811,"journal":{"name":"Indian Journal of Medical Specialities","volume":"13 1","pages":"231 - 235"},"PeriodicalIF":0.6,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44103884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Naltrexone beyond psychiatric domain 纳曲酮超出了精神病学领域
IF 0.6 Q4 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-10-01 DOI: 10.4103/injms.injms_35_22
Ashutosh Garg, Khyati Thapliyal, Vivek Singh
Naltrexone, an opioid receptor (OR) antagonist, at its standard doses, is a United States Federal Drug Administration-approved drug for opioid and alcohol use disorders. However, with the discovery of nonneuropsychiatric effects of OR signaling with low-dose naltrexone, it has found novel applications in inflammatory, malignant, insulin sensitivity-related, and chronic pain conditions. Lower doses also ameliorate its adverse effects. Its off-label use in the abovementioned situations has proven to be cost-effective against costly immunomodulating and antineoplastic drugs. Its lower cost and miniscule margin of interest have precluded in-depth analysis by the pharmaceutical industry. So far, only animal studies, cell culture studies, and case reports have been conducted, some of which exhibit promising benefits. There is a dearth of much-needed quality trials.
纳曲酮是一种阿片受体(OR)拮抗剂,标准剂量,是美国联邦药品管理局批准的治疗阿片类药物和酒精使用障碍的药物。然而,随着低剂量纳曲酮OR信号的非神经精神作用的发现,它在炎症、恶性、胰岛素敏感性相关和慢性疼痛条件下有了新的应用。较低的剂量也能减轻其不良影响。它在上述情况下的标示外使用已被证明对昂贵的免疫调节和抗肿瘤药物具有成本效益。其较低的成本和极小的利润率阻碍了制药行业的深入分析。到目前为止,只进行了动物研究、细胞培养研究和病例报告,其中一些研究显示出了有希望的益处。缺乏急需的高质量试验。
{"title":"Naltrexone beyond psychiatric domain","authors":"Ashutosh Garg, Khyati Thapliyal, Vivek Singh","doi":"10.4103/injms.injms_35_22","DOIUrl":"https://doi.org/10.4103/injms.injms_35_22","url":null,"abstract":"Naltrexone, an opioid receptor (OR) antagonist, at its standard doses, is a United States Federal Drug Administration-approved drug for opioid and alcohol use disorders. However, with the discovery of nonneuropsychiatric effects of OR signaling with low-dose naltrexone, it has found novel applications in inflammatory, malignant, insulin sensitivity-related, and chronic pain conditions. Lower doses also ameliorate its adverse effects. Its off-label use in the abovementioned situations has proven to be cost-effective against costly immunomodulating and antineoplastic drugs. Its lower cost and miniscule margin of interest have precluded in-depth analysis by the pharmaceutical industry. So far, only animal studies, cell culture studies, and case reports have been conducted, some of which exhibit promising benefits. There is a dearth of much-needed quality trials.","PeriodicalId":43811,"journal":{"name":"Indian Journal of Medical Specialities","volume":"13 1","pages":"211 - 215"},"PeriodicalIF":0.6,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43397396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exudative retinal detachment: An unusual ocular manifestation of syphilis 渗出性视网膜脱离:梅毒的一种不寻常的眼部表现
IF 0.6 Q4 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-10-01 DOI: 10.4103/injms.injms_62_22
Belfaiza Soukaina, Abdellaoui Taoufiq, Fiqhi Issam, Mouzari Yassine, R. Karim, Oubaaz Bar
Ocular syphilis is a disease known as a great simulator.It can affect the structures of the eye. It often manifests by an anterior uveitis. Posterior segment involvement is very rare and it is exceptionally complicated by exudative retinal detachment. We report the case of a patient with bilateral bullous retinal detachment in the context of ocular syphilis with a good evolution after treatment by penicillin G and corticotherapy.
眼梅毒是一种被称为伟大模拟器的疾病。它会影响眼睛的结构。它通常表现为前葡萄膜炎。后段受累非常罕见,渗出性视网膜脱离异常复杂。我们报告了一例患有双侧大疱性视网膜脱离的眼梅毒患者,经青霉素G和皮质类固醇治疗后进展良好。
{"title":"Exudative retinal detachment: An unusual ocular manifestation of syphilis","authors":"Belfaiza Soukaina, Abdellaoui Taoufiq, Fiqhi Issam, Mouzari Yassine, R. Karim, Oubaaz Bar","doi":"10.4103/injms.injms_62_22","DOIUrl":"https://doi.org/10.4103/injms.injms_62_22","url":null,"abstract":"Ocular syphilis is a disease known as a great simulator.It can affect the structures of the eye. It often manifests by an anterior uveitis. Posterior segment involvement is very rare and it is exceptionally complicated by exudative retinal detachment. We report the case of a patient with bilateral bullous retinal detachment in the context of ocular syphilis with a good evolution after treatment by penicillin G and corticotherapy.","PeriodicalId":43811,"journal":{"name":"Indian Journal of Medical Specialities","volume":"13 1","pages":"246 - 248"},"PeriodicalIF":0.6,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48243988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cutaneous leukocytoclastic vasculitis after ChAdOx1 nCoV-19 vaccine ChAdOx1-nCoV-19疫苗接种后的皮肤白细胞破裂性血管炎
IF 0.6 Q4 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-10-01 DOI: 10.4103/injms.injms_87_22
M. Abdulla
{"title":"Cutaneous leukocytoclastic vasculitis after ChAdOx1 nCoV-19 vaccine","authors":"M. Abdulla","doi":"10.4103/injms.injms_87_22","DOIUrl":"https://doi.org/10.4103/injms.injms_87_22","url":null,"abstract":"","PeriodicalId":43811,"journal":{"name":"Indian Journal of Medical Specialities","volume":"13 1","pages":"263 - 264"},"PeriodicalIF":0.6,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43437473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The posterior fossa intracranial pressure monitoring in neurocritical care: It is time to evaluate objectively in forbidden territories 后窝颅内压监测在神经危重症监护中的应用:是时候客观评价禁区了
IF 0.6 Q4 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-10-01 DOI: 10.4103/injms.injms_72_22
Tariq Janjua, L. Moscote-Salazar, W. Florez-Perdomo
{"title":"The posterior fossa intracranial pressure monitoring in neurocritical care: It is time to evaluate objectively in forbidden territories","authors":"Tariq Janjua, L. Moscote-Salazar, W. Florez-Perdomo","doi":"10.4103/injms.injms_72_22","DOIUrl":"https://doi.org/10.4103/injms.injms_72_22","url":null,"abstract":"","PeriodicalId":43811,"journal":{"name":"Indian Journal of Medical Specialities","volume":"13 1","pages":"260 - 260"},"PeriodicalIF":0.6,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42468207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of SARS-CoV-2 vaccination on severity and outcome of COVID-19 among health-care workers of a tertiary care hospital in India 印度一家三级护理医院医护人员接种SARS-CoV-2疫苗对新冠肺炎严重程度和结果的影响
IF 0.6 Q4 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-10-01 DOI: 10.4103/injms.injms_56_22
R. Gaind, N. Gupta, Ravindra Nath, Nilushree Srivastava, Tanushree Gahlot, P. Ish, Nitesh Gupta
Introduction: SARS-CoV-2 vaccines decrease the risk of infection. However, data on the utility of vaccines in decreasing the severity of COVID-19 need to be evaluated. This study was carried out with the primary objective to assess the severity and clinical outcome of COVID-19 infections among unvaccinated and vaccinated health-care workers (HCWs). Methods: This was a hospital-based retrospective cohort study including all HCWs who developed microbiologically confirmed COVID-19 over 6 months from January 31, 2021, to July 31, 2021 (during the second wave of COVID-19 in India). Data were recorded through a questionnaire which included demographic details, primary location of work, history of vaccination with dates, comorbidities, severity of COVID-19, and outcome. HCWs who tested positive for SARS-CoV-2 before any dose of the COVID-19 vaccine were included in the “unvaccinated” group. Whereas HCWs who developed SARS-CoV-2 after a single or both doses of vaccine were included in the vaccinated group. The outcome and mortality among the vaccinated and unvaccinated groups were evaluated and compared. Results: The study included 500 HCWs who developed a microbiologically confirmed CVOID-19 infection. It was a predominantly middle-aged population with 247 unvaccinated and 253 vaccinated at the time of developing COVID-19. Only one-fourth of the population (26%) was working in the COVID-19 area and the source of COVID-19 to most was either a COVID-19 patient (39%) or a colleague (38%). Around 13% of the population had comorbidities with cardiovascular disease and diabetes being the most common. The majority of the patients were mild (71%) and most were treated at home in isolation (91%). Only 4% of the study population required intensive care. Among the vaccinated group, COVID-19 infection was predominantly mild and this difference was statistically significant as compared to the nonvaccinated. No difference was found in mortality among the two groups; however, the overall mortality was only 1%. Conclusions: SARS-CoV-2 vaccines reduce the severity of COVID-19 besides preventing infections and its spread. This can help in effective care of COVID-19 in home isolation without overburdening the health-care services. More studies including clinical parameters and microbiological components are required to understand the true extent of this protection of vaccines from severe forms of COVID-19.
引言:严重急性呼吸系统综合征冠状病毒2型疫苗可降低感染风险。然而,需要评估疫苗在降低新冠肺炎严重程度方面的效用数据。本研究的主要目的是评估未接种疫苗和接种疫苗的医护人员(HCW)中新冠肺炎感染的严重程度和临床结果。方法:这是一项基于医院的回顾性队列研究,包括2021年1月31日至2021年7月31日(在印度第二波新冠肺炎期间)6个月内发生微生物确诊的新冠肺炎的所有HCW。数据通过问卷记录,其中包括人口统计详细信息、主要工作地点、接种史和日期、合并症、新冠肺炎严重程度和结果。在接种任何一剂新冠肺炎疫苗之前,SARS-CoV-2检测呈阳性的医务人员被纳入“未接种疫苗”组。而在单剂或两剂疫苗接种后出现严重急性呼吸系统综合征冠状病毒2型的HCW被纳入接种组。对接种疫苗组和未接种疫苗组的结果和死亡率进行了评估和比较。结果:该研究包括500名经微生物证实感染CVOID-19的HCW。这是一个以中年人口为主的群体,在发展为新冠肺炎时,247人未接种疫苗,253人接种疫苗。只有四分之一的人口(26%)在新冠肺炎地区工作,大多数人的新冠肺炎来源是新冠肺炎患者(39%)或同事(38%)。大约13%的人口患有合并症,其中心血管疾病和糖尿病最为常见。大多数患者病情较轻(71%),大多数患者在家接受隔离治疗(91%)。只有4%的研究人群需要重症监护。在接种疫苗的人群中,新冠肺炎感染主要是轻微的,与未接种疫苗的人相比,这一差异具有统计学意义。两组的死亡率没有差异;但总死亡率仅为1%。结论:SARS-CoV-2疫苗除了预防感染和传播外,还能降低新冠肺炎的严重程度。这有助于在家隔离的情况下有效护理新冠肺炎,而不会使医疗服务负担过重。需要进行更多的研究,包括临床参数和微生物成分,以了解疫苗对严重形式的新冠肺炎的真正保护程度。
{"title":"Effect of SARS-CoV-2 vaccination on severity and outcome of COVID-19 among health-care workers of a tertiary care hospital in India","authors":"R. Gaind, N. Gupta, Ravindra Nath, Nilushree Srivastava, Tanushree Gahlot, P. Ish, Nitesh Gupta","doi":"10.4103/injms.injms_56_22","DOIUrl":"https://doi.org/10.4103/injms.injms_56_22","url":null,"abstract":"Introduction: SARS-CoV-2 vaccines decrease the risk of infection. However, data on the utility of vaccines in decreasing the severity of COVID-19 need to be evaluated. This study was carried out with the primary objective to assess the severity and clinical outcome of COVID-19 infections among unvaccinated and vaccinated health-care workers (HCWs). Methods: This was a hospital-based retrospective cohort study including all HCWs who developed microbiologically confirmed COVID-19 over 6 months from January 31, 2021, to July 31, 2021 (during the second wave of COVID-19 in India). Data were recorded through a questionnaire which included demographic details, primary location of work, history of vaccination with dates, comorbidities, severity of COVID-19, and outcome. HCWs who tested positive for SARS-CoV-2 before any dose of the COVID-19 vaccine were included in the “unvaccinated” group. Whereas HCWs who developed SARS-CoV-2 after a single or both doses of vaccine were included in the vaccinated group. The outcome and mortality among the vaccinated and unvaccinated groups were evaluated and compared. Results: The study included 500 HCWs who developed a microbiologically confirmed CVOID-19 infection. It was a predominantly middle-aged population with 247 unvaccinated and 253 vaccinated at the time of developing COVID-19. Only one-fourth of the population (26%) was working in the COVID-19 area and the source of COVID-19 to most was either a COVID-19 patient (39%) or a colleague (38%). Around 13% of the population had comorbidities with cardiovascular disease and diabetes being the most common. The majority of the patients were mild (71%) and most were treated at home in isolation (91%). Only 4% of the study population required intensive care. Among the vaccinated group, COVID-19 infection was predominantly mild and this difference was statistically significant as compared to the nonvaccinated. No difference was found in mortality among the two groups; however, the overall mortality was only 1%. Conclusions: SARS-CoV-2 vaccines reduce the severity of COVID-19 besides preventing infections and its spread. This can help in effective care of COVID-19 in home isolation without overburdening the health-care services. More studies including clinical parameters and microbiological components are required to understand the true extent of this protection of vaccines from severe forms of COVID-19.","PeriodicalId":43811,"journal":{"name":"Indian Journal of Medical Specialities","volume":"13 1","pages":"216 - 220"},"PeriodicalIF":0.6,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42431165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute hemorrhagic leukoencephalitis in COVID-19 infection COVID-19感染的急性出血性白脑炎
IF 0.6 Q4 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-10-01 DOI: 10.4103/injms.injms_71_22
M. Abdulla
{"title":"Acute hemorrhagic leukoencephalitis in COVID-19 infection","authors":"M. Abdulla","doi":"10.4103/injms.injms_71_22","DOIUrl":"https://doi.org/10.4103/injms.injms_71_22","url":null,"abstract":"","PeriodicalId":43811,"journal":{"name":"Indian Journal of Medical Specialities","volume":"13 1","pages":"261 - 262"},"PeriodicalIF":0.6,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46060221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Indian Journal of Medical Specialities
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1